Cited by 29Genomics and Rare DiseasesGenetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalities

Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder

Open access
Hiatt, Susan M., Thompson, Michelle L., Prokop, Jeremy W., Lawlor, James M.J., Gray, David E., Bebin, E. Martina, Rinne, Tuula, Kempers, Marlies +12 more·2019·The American Journal of Human Genetics

Abstract

Developmental delay and intellectual disability (DD and ID) are heterogeneous phenotypes that arise in many rare monogenic disorders. Because of this rarity, developing cohorts with enough individuals to robustly identify disease-associated genes is challenging. Social-media platforms that facilitate data sharing among sequencing labs can help to address this challenge. Through one such tool, GeneMatcher, we identified nine DD- and/or ID-affected probands with a rare, heterozygous variant in the gene encoding the serine/threonine-protein kinase BRSK2. All probands have a speech delay, and most present with intellectual disability, motor delay, behavioral issues, and autism. Six of the nine variants are predicted to result in loss of function, and computational modeling predicts that the remaining three missense variants are damaging to BRSK2 structure and function. All nine variants are absent from large variant databases, and BRSK2 is, in general, relatively intolerant to protein-altering variation among humans. In all six probands for whom parents were available, the mutations were found to have arisen de novo. Five of these de novo variants were from cohorts with at least 400 sequenced probands; collectively, the cohorts span 3,429 probands, and the observed rate of de novo variation in these cohorts is significantly higher than the estimated background-mutation rate (p = 2.46 × 10-6). We also find that exome sequencing provides lower coverage and appears less sensitive to rare variation in BRSK2 than does genome sequencing; this fact most likely reduces BRSK2's visibility in many clinical and research sequencing efforts. Altogether, our results implicate damaging variation in BRSK2 as a source of neurodevelopmental disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2019.02.002

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies have reported additional individuals with ASD and/or NDD with de novo damaging variants in BRSK2, PAX5, NR4A2, RALGAPB, and DPP6.

    “Recent studies have reported additional individuals with ASD and/or NDD with de novo damaging variants in these genes including BRSK2,27 PAX5,4,28 NR4A2,29,30 RALGAPB,7,31,32 and DPP6.5,33,34”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hiatt, S. M., Thompson, M. L., Prokop, J. W., Lawlor, J. M. J., Gray, D. E., Bebin, E. M., Rinne, T., Kempers, M., Pfundt, R., van Bon, B. W., Mignot, C., Nava, C., Depienne, C., Kalsner, L., Rauch, A., Joset, P., Bachmann-Gagescu, R., Wentzensen, I. M., McWalter, K., & Cooper, G. M.
Affiliations
  • HudsonAlpha Institute for Biotechnology (US)
  • Michigan State University (US)
  • University of Alabama at Birmingham (US)
  • Radboud University Medical Center (NL)
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Sorbonne Université (FR)
  • Connecticut Children's Medical Center (US)
  • University of Zurich (CH)
Corresponding author
Cooper, Gregory M.
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2019-04
Volume
104
Issue
4
Pages
701-708
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2922519375
Cited by
29
References
37
Citations by year
2026: 6 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 1
FWCI
1.35
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • HAL (submittedVersion)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Office of the Director (K01ES025435)
  • GIS-Institut des Maladies Rares
  • National Human Genome Research Institute (UM1HG007301)
  • National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
BRSK2, neurodevelopmental disorders, intellectual disability, developmental delay, de novo mutations, loss-of-function mutations, serine/threonine kinase, autism spectrum disorder, speech delay, protein structure prediction, disease gene identification
MeSH terms
Exome Sequencing, Adolescent, Autistic Disorder, Child, Child Behavior Disorders, Developmental Disabilities, Child, Preschool, Female, Heterozygote, Humans, Male, Intellectual Disability, Mutation, Phenotype, Genetic Variation, Protein Serine-Threonine Kinases, Gene Deletion, Motor Skills Disorders, Genetic Predisposition to Disease, Young Adult, Exome, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review